VIRP
Virbac SA · EURONEXT:VIRP
351.50 EUR−2.50 −0.71%
Virbac SA (EURONEXT:VIRP) last traded at 351.50 EUR, down 0.71% on the day. Over the past year the stock is down 0.99%. Its 52-week range is 297.00 to 389.50. It is in the Health Technology sector (Biotechnology).
Key statistics
Open351.50
Day range350.00 – 354.00
52-week range297.00 – 389.50
Volume4.64 K
Average volume (10 days)4.01 K
Market cap (USD)3.32 B
P/E18.91
EPS (TTM) (USD)21.23
Dividend yield0.41%
Beta (1 year)0.6189
Revenue (TTM) (USD)1.71 B
Employees6.44 K
Performance
+1.44%1 week
+15.62%1 month
+3.38%3 months
−5.13%6 months
−1.40%Year to date
−0.99%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- France's Virbac Q3 revenue rises on strength in Both Companion Animal, Farm Animal segmentsReuters · 19 Oct 2026
- VIRP: YTD growth reached 7.9% CERS, positioning FY2026 revenue guidance at its upper endQuartr · 19 Oct 2026
- Virbac Sees 2026 Targets At Upper End Of RangeReuters · 19 Oct 2026
- VIRBAC: Solid growth of +7.9% at CERS in YTD September 2026, fueled by double-digit growth of our Supercharge platformsGlobeNewswire · 19 Oct 2026
- Virbac : Declaration of the number of shares et voting rights 09/2026GlobeNewswire · 07 Oct 2026
- VIRP: Solid H1 2026 growth and margin expansion support strong full-year outlook and ongoing investmentsQuartr · 18 Sep 2026
- VIRP: 7.4% revenue growth, margin gains, and robust cash flow position H1 2026 for strong full-year resultsQuartr · 18 Sep 2026
- VIRP: H1 2026 revenue up 4.0% to €768M, with higher margins and strong segment growthQuartr · 18 Sep 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.